Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of personalized cholic acid capsules in bile acid synthesis defects
2019-001528-37Phase 4Active
- Sponsor
- Cbusinez
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cholic acid in Bile Acid Synthesis Defects (BASD) and Zellweger spectrum disorder (PBD-ZSD), sponsored by Cbusinez. Primary endpoint: Type and number of adverse events and side effects. Started Apr 2020; status: active.
02
Drugs
cholic acid
03
Conditions
Bile Acid Synthesis Defects (BASD)Zellweger spectrum disorder (PBD-ZSD)
Beyond the preview
Go deeper on 2019-001528-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001528-37.